3,4-methylenedioxyamphetamine has been researched along with Depression, Postpartum in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Depression, Postpartum: Depression in POSTPARTUM WOMEN, usually within four weeks after giving birth (PARTURITION). The degree of depression ranges from mild transient depression to neurotic or psychotic depressive disorders. (From DSM-IV, p386)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lehti, J | 1 |
| Furuichi, A | 1 |
| Mizobe, K | 1 |
| Nukina, S | 1 |
| Kawahara, R | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Depression, Postpartum
| Article | Year |
|---|---|
Theory of psychological adaptive modes.
Topics: Adaptation, Psychological; Adjustment Disorders; Anxiety; Bipolar Disorder; Depression; Depression, | 2016 |
[Case of bonding disorder effectively treated by Naikan therapy].
Topics: Adult; Depression, Postpartum; Female; Humans; International Classification of Diseases; Love; Mothe | 2006 |